Glecaprevir plus pibrentasvir for paediatric hepatitis C infection

被引：0
|
作者：
Baker, Holly
机构：
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2021年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：428 / 428
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection
    Toyoda, Hidenori
    Chayama, Kazuaki
    Suzuki, Fumitaka
    Sato, Ken
    Atarashi, Tomofumi
    Watanabe, Tsunamasa
    Atsukawa, Masanori
    Naganuma, Atsushi
    Notsumata, Kazuo
    Osaki, Yukio
    Nakamuta, Makoto
    Takaguchi, Koichi
    Saito, Satoru
    Kato, Koji
    Pugatch, David
    Burroughs, Margaret
    Redman, Rebecca
    Alves, Katia
    Pilot-Matias, Tami J.
    Oberoi, Rajneet K.
    Fu, Bo
    Kumada, Hiromitsu
    HEPATOLOGY, 2018, 67 (02) : 505 - 513
  • [32] Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial
    Dore, Gregory J.
    Feld, Jordan J.
    Thompson, Alex
    Martinello, Marianne
    Muir, Andrew J.
    Agarwal, Kosh
    Mullhaupt, Beat
    Wedemeyer, Heiner
    Lacombe, Karine
    Matthews, Gail V.
    Schultz, Michael
    Klein, Marina
    Hezode, Christophe
    Mercade, Gerard Estivill
    Kho, Danny
    Petoumenos, Kathy
    Marks, Philippa
    Tatsch, Fernando
    Dos Santos, Ana Gabriela Pires
    Gane, Ed
    Trinh, Roger
    Erratt, Amanda
    Mercade, Gerard Estivill
    Quiene, Sophie
    Shaw, Ineke
    Filep, Ecaterina
    Martinello, Marianne
    Petoumenos, Kathy
    Roberts, Stuart
    Foster, Graham
    Curry, Michael
    Warlow, Jenny
    Mauss, Stefan
    Stedman, Catherine
    Vachon, Marie-Louise
    Christensen, Stefan
    Muir, Andrew
    Schultz, Michael
    Baker, David
    Ramji, Alnoor
    Cornberg, Markus
    Bloch, Mark
    Hezode, Christophe
    Bourliere, Marc
    Lacombe, Karine
    Semmo, Nasser
    Agarwal, Kosh
    Cannon, Mary
    Tam, Edward
    Klein, Marina
    JOURNAL OF HEPATOLOGY, 2020, 72 (03) : 431 - 440
  • [33] Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
    Alessio Aghemo
    Yves Horsmans
    Stefan Bourgeois
    Mark Bondin
    Michael Gschwantler
    Harald Hofer
    Nasser Semmo
    Francesco Negro
    Zhenzhen Zhang
    John Marcinak
    Ella Veitsman
    Rawi Hazzan
    Konstantinos Mimidis
    Ioannis Goulis
    Nuno Marques
    Robert Flisiak
    Wlodzimierz Mazur
    Carlos Roncero
    Fiona Marra
    Georges Philippe Pageaux
    Tarik Asselah
    Pietro Lampertico
    Infectious Diseases and Therapy, 2021, 10 : 2203 - 2222
  • [34] Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older
    Komaki, Yuri
    Ozono, Yoshinori
    Nakamura, Kenichi
    Iwakiri, Hisayoshi
    Hasuike, Satoru
    Sueta, Mitsue
    Miike, Tadashi
    Yamamoto, Shojiro
    Uto, Hirofumi
    Kusumoto, Kazunori
    Ochiai, Toshimasa
    Kato, Junya
    Komada, Naoto
    Kuroki, Kazuo
    Eto, Toshiharu
    Shigehira, Masafumi
    Hirono, Shuichi
    Nagata, Kenji
    Kawakami, Hiroshi
    BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [35] Hepatitis C and beta-thalassemia major in children: experience with glecaprevir/pibrentasvir
    Quintero Garcia, Diannet
    Sebastian Cuevas, Francisco Jose
    Crehua Gaudiza, Elena
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (02) : 150 - +
  • [36] Glecaprevir plus pibrentasvir for HCV with severe renal impairment
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 852 - 852
  • [37] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
    Liu, Chen-Hua
    Liu, Chun-Jen
    Hung, Chien-Ching
    Hsieh, Szu-Min
    Su, Tung-Hung
    Sun, Hsin-Yun
    Tseng, Tai-Chung
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    LIVER INTERNATIONAL, 2020, 40 (04) : 758 - 768
  • [38] Glecaprevir/pibrentasvir
    Arora, Rishi
    Martin, Michelle T.
    Boike, Justin
    Patel, Sonalie
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (02) : 318 - 320
  • [39] Efficacy and safety of glecaprevir and pibrentasvir in Saudi patients with chronic hepatitis C virus infection at a major tertiary hospital
    Ruwayni, Ali A.
    Alobary, Eman E.
    Alyahya, Khalid M.
    SAUDI MEDICAL JOURNAL, 2024, 45 (01) : 34 - 39
  • [40] Histological improvement in chronic hepatitis C-autoimmune hepatitis overlap syndrome by glecaprevir and pibrentasvir
    Kotaro Matsumoto
    Kentaro Kikuchi
    Yuta Namura
    Ayako Watanabe
    Hiromichi Tsunashima
    Shinpei Doi
    Clinical Journal of Gastroenterology, 2023, 16 : 572 - 579
12345